The National Osteoporosis Guideline Groups new guidelines: what is new?
M. Bukhari1 1University Hospitals of Morecambe Bay, NHS Trust, Royal Lancaster Infirmary, Lancaster and Clinical Sciences, University of Liverpool, Liverpool, UK Correspondence to: M. Bukhari, Department of Rheumatology, Royal Lancaster Infirmary, Ashton road, Lancaster LA1 4RP, UK. E-mail: marwan.bukhari{at}mbht.nhs.uk’ + u + ‘@’ + d + ”//–> Introduction The importance of osteoporosis (OP) to the health economy is widely documented [1]: with costs of fractures alone of £1.73 billion, the ageing population also will lead to a doubling of this estimated cost. Recent advances in the literature regarding the diagnoses and management of OP have occurred. Although there have been Royal College of Physicians (RCP) guidelines published in 1999, 2000 and 2002 [2–4] and National Institute for Healthcare and Clinical Excellence (NICE) guidances and the new final appraisal determination document from NICE [5–7], they have not been updated with recent advances including the newly developed World
